university medical center omaha ne

university medical center omaha ne
The U.S. Food and Drug Administration (FDA) has noted, some hospitals and medical centers are still the storage of potentially contaminated heparin in their deliveries, showing that they failed to respond to recall notices and warnings about the blood thinner from Baxter International.

A spokeswoman for the FDA said that medical facilities in California were in a letter on 2 May on the gaps in the recall response, and if they follow with a check, they found that "more than a handful of hospitals did not have all the contaminated heparin," ", reported the Wall Street Journal.

She said they found the product to "crash carts, catheter labs, and even a hospital pharmacist on the shelf." "

Heparin is used in operating theaters and kidney dialysis centers to stop potentially fatal blood clots. The contaminated products made by Baxter International, has been with severe allergic reactions and more than 80 deaths, and investigations conducted by the FDA, on the basis of results from multiple laboratories, this may be a contamination, the raw material from a company in China.

The FDA has memories, because there are differences in the response to the alerts and recalls by the agency and the manufacturer, and also because of the information from the California Department of Health.

The memory, which the Wall Street Journal, asks each:

"" Spread the word about recalls of injectable heparin products and heparin solutions, the flush may be contaminated with oversulfated chondroitin sulfate (OSCS) "."

"Affected heparin products have been in the medical care in a state since the recall announcement," said the FDA.

In the meantime, Chinese officials deny that the oversulfated chondroitin sulfate system is to blame for the deaths and has accused Baxter of disability with their own investigation, according to a report by Reuters at a press conference last Tuesday by Jin Shaohong, the China National Institute for the control of pharmaceutical and biological products.

She said the side effects and deaths were only in the U.S. and Germany and other countries have also found that the contamination in the heparin products are not all the reactions reported.

The Chinese authorities assert that the health effects were also associated with lots that do not have the pollutants that are on their own tests. Earlier this month, the FDA denied this was the case because she and other laboratories had also tested these batches and found the contamination.

The contaminant has the same proportion of chemical elements such as heparin, and very sophisticated devices with MRI is necessary to provide the difference between heparin (derived from pig intestines and expensive to source in China since the outbreak of pig disease) and pollution (which is much cheaper from animal cartilage).

The Chinese authorities have accused Baxter destroy samples and records it as a key to their investigation, but according to Reuters, that was not from a Baxter spokesman in China.